Internal Medicine, Gastroenterology · Crystal River, FL
NPI
1437425790
Since 2012
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6410 W Gulf to Lake Hwy
Crystal River, FL, 34429
Phone (352) 563-2450
Groups this clinician bills Medicare through
Medicare paid, 2024
$276K
3,181 services
Medicare patients, 2024
755
Average age 74
Drug cost, 2024
$465K
1,607 prescriptions
Company payments, 2025
$669
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Trupti S Shinde was code 88305 (surgical pathology examination), 780 times for 303 patients. In total Trupti S Shinde billed 3,181 services in 36 codes, and Medicare paid $276K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 780 | 303 | $55.75 | $43K |
| 99213 Office E&M - Established | Office | 320 | 259 | $63.78 | $20K |
| 88313 Surgical Pathology Examination | Office | 302 | 168 | $64.75 | $20K |
| 43239 Upper GI Endoscopy | Facility | 202 | 192 | $94.72 | $19K |
| 88312 Surgical Pathology Examination | Office | 193 | 121 | $88.11 | $17K |
| 99214 Office E&M - Established | Office | 192 | 163 | $94.58 | $18K |
| 88360 Immunohistochemistry | Office | 162 | 118 | $94.60 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 137 | 96 | $97.11 | $13K |
| 99223 Hospital E&M - Initial | Facility | 122 | 120 | $141.87 | $17K |
| 45385 Colonoscopy - Lesion Removal | Facility | 116 | 115 | $211.58 | $25K |
| 99204 Office E&M - New | Office | 108 | 108 | $122.40 | $13K |
| 99203 Office E&M - New | Office | 95 | 95 | $75.99 | $7,219 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 88 | 71 | $80.20 | $7,057 |
| 45380 Lower GI Endoscopy - Other | Facility | 79 | 78 | $119.95 | $9,476 |
| 88342 Immunohistochemistry | Office | 51 | 31 | $83.29 | $4,248 |
By year: 2022 $328K for 4,304 services; 2023 $282K for 3,244 services; 2024 $276K for 3,181 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 780 | 303 | $55.75 | $43K |
| 88313 Surgical Pathology Examination | 302 | 168 | $64.75 | $20K |
| 88312 Surgical Pathology Examination | 193 | 121 | $88.11 | $17K |
| 88360 Immunohistochemistry | 162 | 118 | $94.60 | $15K |
| 88342 Immunohistochemistry | 51 | 31 | $83.29 | $4,248 |
Medicare prescription drug claims, 2024
In 2024, the drug Trupti S Shinde prescribed most often to Medicare patients was Omeprazole, with 493 prescriptions and refills. In total Trupti S Shinde wrote 1,607 Medicare prescriptions that cost $465K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 493 | 1,005 | 227 | $6,861 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 348 | 348 | 340 | $60K |
| Famotidine Generic | 134 | 319 | 49 | $2,316 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 122 | 133 | 120 | $2,147 |
| Pantoprazole Sodium Generic | 55 | 133 | 23 | $720 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 41 | 41 | 37 | $660 |
| Linzess Linaclotide | 38 | 88 | 12 | $47K |
| Colestipol Hcl Generic | 34 | 65 | 13 | $2,735 |
| Hydrocortisone Generic | 28 | 28 | 21 | $803 |
| Mesalamine Er Mesalamine | 23 | 58 | Under 11 | $6,581 |
| Creon Lipase/Protease/Amylase | 20 | 31 | Under 11 | $75K |
| Carvedilol Generic | 20 | 28 | Under 11 | $111 |
| Lubiprostone Generic | 19 | 33 | Under 11 | $2,670 |
| Ursodiol Generic | 18 | 44 | Under 11 | $3,747 |
| Sucralfate Generic | 14 | 16 | 11 | $162 |
Brand drugs: 482 claims; generic drugs: 1,125 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Trupti S Shinde $669 ($669 in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbvie Inc. with $296.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 12 | $296 |
| Gilead Sciences, Inc. GILD | 3 | $197 |
| Pfizer Inc. PFE | 2 | $42.33 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $37.52 |
| Madrigal Pharmaceuticals MDGL | 1 | $33.33 |
| Novo Nordisk Inc NVO | 1 | $32.1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $19.5 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $10.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.